2013
DOI: 10.1182/blood.v122.21.5600.5600
|View full text |Cite
|
Sign up to set email alerts
|

Clintrial Refer- a Mobile App To Connect Patients With Local Clinical Trials

Abstract: Background Readily accessible, smart-phone applications (Apps) have the potential to revolutionise and improve the delivery of patient care. Significant challenges associated with recruiting patients to haematology clinical trials include the rarity of diseases, complexity of trials, limited site locations, and maintaining knowledge of current trials in the context of rapid therapeutic developments. The Haematology Clinical Research Network, of New South Wales and the Australian Capital Terri… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…While high quality, scope is very limited to common areas and well established treatments; thus it lacks both the breadth and recency requirements of paediatrics, rare cancers and access to the latest treatments. Specialist clinical trials recommender systems do cover the latest treatments and support clinician filters [3,16]. However, such systems are nearly always specific to one medical area (e.g., haematology) and thus do not cover the breadth needed for paediatric oncology, nor the nuances of paediatrics.…”
Section: Comparison With Other Systemsmentioning
confidence: 99%
“…While high quality, scope is very limited to common areas and well established treatments; thus it lacks both the breadth and recency requirements of paediatrics, rare cancers and access to the latest treatments. Specialist clinical trials recommender systems do cover the latest treatments and support clinician filters [3,16]. However, such systems are nearly always specific to one medical area (e.g., haematology) and thus do not cover the breadth needed for paediatric oncology, nor the nuances of paediatrics.…”
Section: Comparison With Other Systemsmentioning
confidence: 99%